S&P 500Bucket avgCompareDividend-adjusted total return · S&P 500 uses VOO · Nov 12, 2026 – Nov 19, 2026
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.3% | −5.2% | −5.0% | −12.7% | +4.3% | +10.3% | +61.8% | +12.9% | — | +21.9% |
| Peer average | −2.0% | −4.2% | −3.3% | −7.9% | +11.4% | +17.4% | +48.7% | +24.3% | +160.4% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$21 of every $1,000 in MMSC is Xometry,
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XMTRXometry, () | Industrials | 2.08% | $208.45 | 8,628 | $1.0M |
| 2 | FROGJFrog | Technology | 1.97% | $197.00 | 8,589 | $982K |
| 3 | —US Dollar | — | 1.88% | $188.35 | 939K | $939K |
| 4 | ZETAZETA Global () | Technology | 1.66% | $165.77 | 24K | $827K |
| 5 | OLLIOllie's Bargain Outlet | Consumer Defensive | 1.59% | $159.09 | 8,127 | $793K |
| 6 | NTSKNetskope, () | Technology | 1.54% | $154.24 | 33K | $769K |
| 7 | SAILSailPoint | Technology | 1.43% | $143.37 | 32K | $715K |
| 8 | VRNSVaronis Systems | Technology | 1.37% | $137.41 | 14K | $685K |
| 9 | TVTXTravere Therapeutics | Healthcare | 1.32% | $131.88 | 13K | $658K |
| 10 | SYRESpyre Therapeutics | Healthcare | 1.24% | $124.01 | 6,095 | $618K |
| 11 | GHGuardant Health | Healthcare | 1.23% | $122.59 | 4,212 | $611K |
| 12 | PTGXProtagonist Therapeutics | Healthcare | 1.12% | $111.89 | 4,388 | $558K |
| 13 | RGENRepligen | Healthcare | 1.12% | $111.53 | 3,221 | $556K |
| 14 | TWSTTwist Bioscience | Healthcare | 1.02% | $102.17 | 4,379 | $509K |
| 15 | LGNDLigand Pharmaceuticals () | Healthcare | 1.02% | $102.07 | 1,704 | $509K |
of the $573B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XMTR | Xometry, () | 2.08% |
| 2 | FROG | JFrog | 1.97% |
| 3 | ZETA | ZETA Global () | 1.66% |
| 4 | OLLI | Ollie's Bargain Outlet | 1.59% |
| 5 | NTSK | Netskope, () | 1.54% |
| 6 | SAIL | SailPoint | 1.43% |
| 7 | VRNS | Varonis Systems | 1.37% |
| 8 | TVTX | Travere Therapeutics | 1.32% |
| 9 | SYRE | Spyre Therapeutics | 1.24% |
| 10 | GH | Guardant Health | 1.23% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $0.0854 |